Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Epidemiology

What is Tumorigenesis?

What Causes Cancer?

Cancer Prognosis

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Metastatic Migration in Cancer may be Influenced by Metabolism

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Pain

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Myc Mutations and Cancer

Cancer History

See more featured articles »

Cancer Screening Considerations: Balancing the Benefits and Risks

The Biochemistry of Breast Cancer Screening

Effects of Social and Economic Deprivation on Cancer Mortality

Secondary Brain Cancer

Overview of Cell Viability and Cytotoxicity

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

What is the Tumor Microenvironment?

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Caring for a Loved One with Cancer

Secondary Lung Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Glossary

Acidosis and Tumor Progression

Cancer Classification

Is Cancer a Metabolic Disorder?

Cancer Prevention: Lowering your Risk

Extracellular Vesicles as Floating Cancer Biomarkers

The Effects of Cancer on Family Life

Cancer Symptoms

Insight into Cancer Vaccines

Insights into Oncofertility

Cancer Management

Cutaneous Manifestations of Internal Malignancy

Why are Cancer Cell Lines Useful?

Hypoxia Markers and Their Importance

What is Cancer?

Assay for Monitoring and Treating Malignant Brain Tumors

Using Biomarkers to Detect Cancer

Pediatric Cancer

Investigating the Molecular Mechanisms of Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

TARDIS: The Improved Method of Detecting Breast Cancer

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Targeted Cancer Therapies

Transforming Cancer Care through Genomic Testing

Living with Cancer Pain

What Role do Biobanks Play in Cancer Research?

Cancer Pain Management

What is Cancer of Unknown Primary?

The Cancer Cell Surface Proteome as a Therapeutic Target

What is Merkel Cell Carcinoma?

Cancer Diagnosis

CDK9 and Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Research

Hot vs Cold: the differences between tumor types

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Pathophysiology

What is Immunochemotherapy?

British Pioneers in Cancer Biology

Latest Cancer News and Research

Nicotine e-cigarettes help more smokers quit than conventional methods

Nicotine e-cigarettes are more effective in helping people quit smoking than many conventional methods such as nicotine gums and patches and quitting with behavioural support or no support at all, an updated Cochrane review finds.

25 Aug 2026

Protecting the thymus may improve lung cancer treatment outcomes

Building on recent discoveries about the adult thymus, Mass General Brigham investigators used artificial intelligence to show that incidental radiation exposure to the thymus may influence outcomes in patients with lung cancer.

25 Aug 2026

Scientists found a distinct gut microbiome pattern in people with symptomatic diverticular disease

A multicenter Japanese study found that symptomatic uncomplicated diverticular disease (SUDD) was associated with reduced gut microbial diversity, increased abundance of the Ruminococcus gnavus group, and depletion of Coprococcus and other butyrate-producing bacteria. Predictive microbiome analysis also identified enrichment of pathways linked to exopolysaccharide biosynthesis and the cell cycle, although the observational design means these associations cannot establish causality.

25 Aug 2026

Study links thymus radiation to worse lung cancer outcomes

Until recently, the thymus was thought to be of little use beyond puberty, but new research has shown that radiation to the organ is associated with worse outcomes in patients being treated for non-small cell lung cancer (NSCLC).

25 Aug 2026

Researchers traced lifelong obesity resistance in mice back to an early microbial encounter

Natural wild-derived microbiota protected mice against diet-induced obesity across sexes, genetic backgrounds, and age by increasing energy expenditure and promoting a thermogenic program in brown adipose tissue. The effect depended on the immune system’s initial encounter with the microbiota and required CCR2-associated myeloid activity, revealing a long-lasting microbiota-immune-brown fat pathway.

25 Aug 2026

Emergency diagnoses of medical conditions predict worse patient survival

Patients diagnosed with conditions after an emergency hospital admission or an emergency room visit face a higher risk of death than those diagnosed in non-emergency settings, according to a large population-based study by Emma Whitfield and colleagues from University College London, UK, published August 25th in the open access journal PLOS Medicine.

25 Aug 2026

NIH grants support research on whether PFAS exposure increases risk of liver and endometrial cancers

Researchers at the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center have received two grants from the National Institutes of Health (NIH) totaling $7.5 million to study whether exposure to per- and polyfluoroalkyl substances (PFAS), the synthetic compounds known as "forever chemicals," increases the risk of liver cancer and endometrial cancer.

25 Aug 2026

SBRT improves bowel health related quality-of-life in patients with localized intermediate-risk prostate cancer

Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) to moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate risk prostate cancer indicate that the use of SBRT improved bowel health related quality of life (HRQOL) in this patient population.

25 Aug 2026

Gene removal makes engineered immune cells more effective against osteosarcoma

Scientists at St. Jude Children's Research Hospital have discovered that removing the gene for Regnase-1 from engineered immune cells makes them more effective at treating relapsed osteosarcoma.

25 Aug 2026

Standard memory tests fail to detect post-chemotherapy brain fog

Standard memory tests such as word-pair or list-learning tests used in clinics may fail to detect the real-life memory problems reported by many female breast cancer survivors after chemotherapy.

25 Aug 2026

New discovery helps identify colorectal cancer patients at risk for metastasis

Researchers from the University of Turku in Finland and Gustave Roussy Institute in France have discovered a molecular mechanism that regulates whether the cells of an aggressive colorectal cancer are conventional or inverted when they spread in the body.

25 Aug 2026

New machine learning tool identifies hidden epigenetic disease patterns

In a study recently published in Nature Communications, researchers from Berlin, Potsdam, and Jena present a new method for analyzing the epigenome, the genome's control system that determines which genes are switched on and off.

25 Aug 2026

What decades of wine research can, and cannot, tell us about health

A narrative review found that moderate wine intake has repeatedly been associated with lower all-cause and cardiovascular mortality, with proposed mechanisms involving ethanol and grape-derived polyphenols, but the evidence remains largely observational and cannot establish causation. The authors argue that drinking pattern, beverage type, age, cancer risk, and risk-modeling choices all influence how the J-shaped association should be interpreted and how alcohol guidelines are developed.

25 Aug 2026

Protein degrader shows strong activity against treatment-resistant blood cancers

A first-in-class therapy to target MYC, one of the most sought-after and difficult targets in cancer biology, showed promise in hard-to-treat blood cancers, according to a new preclinical study from The University of Texas MD Anderson Cancer Center published in Blood.

24 Aug 2026

Researchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetes

A large retrospective cohort study found that GLP-1 receptor agonist use was associated with a lower risk of tuberculosis in people with type 2 diabetes compared with sulfonylureas, metformin, DPP-4 inhibitors, and SGLT2 inhibitors. The observational findings suggest a possible benefit beyond metabolic control, but the authors emphasize that prospective and mechanistic studies are needed to determine whether GLP-1 therapies themselves reduce TB risk.

24 Aug 2026

Tick-borne alpha-gal syndrome poses potential risks during blood transfusions

A new multi-institute study led by researchers at Dartmouth Health and Geisel School of Medicine at Dartmouth suggests that alpha-gal syndrome, the tick-borne disease that can result in a chronic allergy to meat and animal byproducts, also may complicate certain patients' ability to safely receive a blood plasma or platelet transfusion.

24 Aug 2026